|
Market Cap (25-Jun) $27,342,400 (1,032nd) |
Close (30-Jun) $0.008 |
Volume (30-Jun) 285,280 |
Shortsold (12-Dec) 6,497 (0.00%) (681st) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.09 |
EX1 released this announcement to the ASX on 9 March 2023, 12:28. The announcement is not marked as price sensitive, and is 10 page(s) in length and 269.07kb in size.
You can view all announcements from EX1 and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from EX1 | |
|---|---|
| Initial Director's Interest Notice - MD | 22 June 2023, 11:52 |
| Change of Director's Interest Notice - CB | 22 June 2023, 11:51 |
| Final Director's Interest Notice - JW | 22 June 2023, 11:50 |
| Notice under s708A(12C)(e) of the Corporations Act 2001(Cth) | 9 March 2023, 12:28 |
| EX1 to Receive $1m from the Issue of Convertible Notes | 9 March 2023, 12:27 |
| Trading Halt | 9 March 2023, 9:14 |
| EX1 to Receive $0.431m in Prepayment of R&D Tax Incentive | 9 March 2023, 8:10 |
You must be logged in to post a reply.
Exopharm 